LEADER 01212nas  2200445-  450 
001 996324447903316
005 20240604074232.0
011   $a2632-2498
035   $a(DE-599)ZDB3009682-0
035   $a(OCoLC)1096470535
035   $a(CKB)4970000000101785
035   $a(CONSER)--2019243240
035   $a(NjHacI)994970000000101785
035   $a(EXLCZ)994970000000101785
100   $a20190408a20199999  o--         -
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aNeuro-oncology advances
210  1$a[Oxford] :$cOxford University Press,$d[2019]-
215   $a1 online resource
517 1 $aNOA
531 10$aNeurooncol Adv
606   $aBrain$xCancer
606   $aBrain$xCancer$vPeriodicals
608   $aPeriodical.
608   $aPeriodicals.$2fast
615  0$aBrain$xCancer.
615  0$aBrain$xCancer
676   $a616.99481
712 02$aSociety for Neuro-Oncology,
712 02$aEuropean Association of NeuroOncology,
801  0$bNjHacI
801  1$bNjHacl
906   $aJOURNAL
912   $a996324447903316
996   $aNeuro-oncology advances$92048119
997   $aUNISA